ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
DSM has halted talks with North China Pharmaceutical Group about forming a vitamins and anti-infectives joint venture. The two companies had been in talks since 2004 and signed joint-venture contracts earlier this year. DSM says it recently learned that there has been a “change in the ownership of North China” that would delay implementation of the joint venture. DSM says it may resume discussions with North China in the future or start working with other partners.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X